Click here to view the Blue Cross Blue Shield Tennessee Medical Policy Updates » July 2019 BCBS Tennessee Medical Policy Updates: Ablation Procedure for Peripheral Neuromas Ado-Trastuzumab Emtansine Aldesleukin Atezolizumab Autonomic Nervous System Testing Avelumab Axicabtagene Ciloleucel Belinostat Bendamustine HCl…
Click here to view the Blue Cross Blue Shield Tennessee Medical Policy Updates » March 2019 BCBS Tennessee Medical Policy Updates: Agalsidase Beta Alemtuzumab Alpha1-Proteinase Inhibitor Therapy Applied Behavioral Analysis (ABA) Atezolizumab Avelumab Belinostat Bendamustine HCl (Bendeka®) Bendamustine HCl (Bendeka®)…
Click here to view the Blue Cross Blue Shield Tennessee Medical Policy Updates » February 2019 BCBS Tennessee Medical Policy Updates: Accelerated Partial Breast Irradiation and Brachytherapy Boost after Breast-Conserving Surgery for Early-Stage Breast Cancer Aldesleukin Alemtuzumab Aqueous Shunts and…
Click here to view the Blue Cross Blue Shield Tennessee Medical Policy Updates » October 2018 BCBS Tennessee Medical Policy Updates: Abatacept Applied Behavioral Analysis (ABA) Bortezomib Bortezomib (Velcade ) C1 Esterase Inhibitor Subcutaneous (Human) (Haegarda®) Certolizumab Pegol Epoetin Alfa-epbx…
Click here to view the Blue Cross Blue Shield Tennessee Medical Policy Updates » September 2018 BCBS Tennessee Medical Policy Updates: Abatacept AbobotulinumtoxinA Agalsidase Beta Alemtuzumab Alglucosidase Alfa Angioplasty and/or Stenting for Intracranial Arterial Disease (IAD) Applied Behavioral Analysis (ABA)…
Click here to view the Blue Cross Blue Shield Tennessee Medical Policy Updates » August 2018 BCBS Tennessee Medical Policy Updates: Abatacept Abatacept Ablation Procedure for Peripheral Neuromas AbobotulinumtoxinA Bariatric Surgery Bendamustine HCl (Bendeka®) Bendamustine HCl (Treanda®) Brachytherapy and Accelerated…
Click here to view the Blue Cross Blue Shield Tennessee Draft Medical Policies » August 2018 BCBS Tennessee Draft Medical Policies: Abatacept Positron Emission Tomography (PET) for Cardiac Applications Acupuncture Positron Emission Tomography (PET) for Oncologic Applications Pegfilgrastim-jmdb Atezolizumab Denosumab…
Click here to view the Blue Cross Blue Shield Tennessee Medical Policy Updates » July 2018 BCBS Tennessee Medical Policy Updates: Abatacept Angioplasty and/or Stenting for Intracranial Arterial Disease (IAD) Artificial Liver Assist Devices for the Treatment of Liver Conditions…
Click here to view the Blue Cross Blue Shield Tennessee Draft Medical Policies » July 2018 BCBS Tennessee Draft Medical Policies: Coronary Computed Tomography Angiograchy (CCTA) Three-Dimensional (3D) Printed Orthopedic Implants Omaizumab (Xoliar) Ocrelizumab Natalizumb Irinontecan Lipsome Injection Octreotide Acetate…
Click here to view the Blue Cross Blue Shield Tennessee Medical Policy Updates » June 2018 Medical Policy Updates: BRCA1, BRCA2 and PALB2 Testing for Breast, Ovarian and Other Cancers Breast Cancer Gene Expression Assays Chromosomal Microarray Analysis for Evaluation…